- 2025-09-16 15:20(D-Arg8)-Inotocin 745816-74-4
- 2025-09-16 15:20MMC(TMZ)-TOC
- 2025-09-16 15:20Urotensin II (114-124), human TFA
- 2025-09-16 15:20(d(CH2)51,Tyr(Me)2,Dab5,Arg8)-Vasopressin (d(CH2)5[Tyr(Me)2, Dab5]AVP) 176714-12-8
- 2025-09-16 15:20Urantide 669089-53-6
- 2025-09-16 15:20MK-4256 1104599-69-0
- 2025-09-16 15:20(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin (SKF 100273) 73168-24-8
- 2025-09-16 15:20UFP-803 TFA
- 2025-09-16 15:20L-803087 TFA 1786412-46-1
- 2025-09-16 15:20UFP-803 879497-82-2
- 2025-09-16 15:20L-779976 214770-19-1
- 2025-09-16 15:20SR 142948 dihydrochloride
- 2025-09-16 15:20J-2156 TFA 2387505-73-7
- 2025-09-16 15:20Palosuran hydrochloride (ACT-058362 hydrochloride) 2469274-58-4
- 2025-09-16 15:19DOTA-LM3 TFA
- 2025-09-16 15:19Palosuran (ACT058362) 540769-28-6
- 2025-09-16 15:19hNTS1R agonist-1
- 2025-09-16 15:19DOTA-LM3 1192362-32-5
- 2025-09-16 15:19GSK 1562590 hydrochloride 1003878-07-6
- 2025-09-16 15:19DOTA-JR11 1039726-31-2
